Pioneering research into the chronic inflammation often seen in certain blood cancers has identified a promising treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.
UVA researchers have developed an algorithm that will improve cancer care by quickly and easily identifying patients who will benefit from powerful cancer drugs called kinase inhibitors.
The discovery of a "master controller" for the brain's immune response could let doctors supercharge the body’s ability to fight a spectrum of devastating neurological diseases.
In addition to making available more lifesaving platelets for transfusion, the discovery could help doctors better treat both cancer and thrombocytopenia, a clotting disorder that often strikes newborns in intensive care.
Fourteen independent community pharmacies will team with UVA Health to help residents of rural Appalachia quit smoking and test the effectiveness of multiple smoking cessation programs, including one based on text messaging. The project ultimately aims to lower the region’s cancer rates, which are among the highest in the country.